MedTrace Logo

Deep Brain Stimulation of Nucleus Accumbens for Chronic and Resistant Major Depressive Disorder

NCT01569711 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 6

Last updated 2015-05-27

No results posted yet for this study

Summary

Depression is a common, recurrent and disabling disorder. Among patients with a chronic course of the disease, 20 to 30% are resistant to antidepressant medications. Among those patients, 50% would not benefit from electroconvulsive therapy (ECT). For such patients, deep brain stimulation (DBS) of nucleus accumbens is considered.

Conditions

  • Major Depressive Disorder, Recurrent, Unspecified

Interventions

PROCEDURE

Deep brain stimulation of nucleus accumbens

* Day0 : surgical placement of electrodes * M1 : stimulation of nucleus accumbens * M5 : stimulation of nucleus accumbens or associative territory of caudate nucleus (if no response observed with nucleus accumbens stimulation)

Sponsors & Collaborators

  • Rennes University Hospital

    lead OTHER

Principal Investigators

  • Millet MD Bruno · Rennes University Hospital

Eligibility

Min Age
30 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-02-28
Primary Completion
2013-05-31
Completion
2013-05-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01569711 on ClinicalTrials.gov